John Greene

John Greene is a declared insider at 3 companies (finance chief); the most frequent names are Discover Financial Services, CRISPR Therapeutics AG and Willis Towers Watson PLC. We count 17 filings; the first trade dates from 4 January 2016 and the latest from 18 May 2025.

In open-market terms, that means 1 purchase worth €298k on one side and 2 sales worth €4.0M on the other. Sales outweigh purchases by €3.7M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Other entries cover 13 share grants. In 2025 alone, the filings show 1 purchase and no sales.

The newest entry dates from 19 May 2025: a transaction, in Discover Financial Services. The most recent open-market purchase was published on 28 February 2025, 597 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.